Outcome after neoadjuvant chemotherapy in elderly breast cancer patients – a pooled analysis of individual patient data from eight prospectively randomized controlled trials

INTRODUCTION: Recent studies showed the high and independent impact of age (<40 years) on pathologic complete response (pCR) and prognosis for patients undergoing neoadjuvant chemotherapy (NACT). Some physicians might not consider elderly patients (>65 years) for NACT due to poor prognosis or...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: von Waldenfels, Gabriel, Loibl, Sibylle, Furlanetto, Jenny, Machleidt, Anna, Lederer, Bianca, Denkert, Carsten, Hanusch, Claus, Kümmel, Sherko, von Minckwitz, Gunter, Schneeweiss, Andreas, Untch, Michael, Rhiem, Kerstin, Fasching, Peter A., Blohmer, Jens-Uwe
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2018
Aiheet:
Research Paper: Gerotarget (Focus on Aging)
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5880594/
https://ncbi.nlm.nih.gov/pubmed/29632634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24586
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia